FdaApplication

ANDA 211865

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSUNSHINE LAKE PHARMA CO LTD
application_typeANDA
approval_date2020-03-23

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products